Trials / Not Yet Recruiting
Not Yet RecruitingNCT07201064
A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma
An Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Guangdong ProCapZoom Biosciences Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is a "3+3" dose-escalation, open-label, multiple-dose clinical trial.
Detailed description
This study is a "3+3" dose-escalation, open-label, multiple-dose clinical trial. To evaluate the safety, tolerability, and preliminary efficacy of SZ1003 injection in patients with advanced hepatocellular carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SZ1003 injection | once every two weeks at a dose of SZ1003 injection per infusion. |
Timeline
- Start date
- 2025-09-25
- Primary completion
- 2027-03-30
- Completion
- 2027-09-30
- First posted
- 2025-10-01
- Last updated
- 2025-10-01
Source: ClinicalTrials.gov record NCT07201064. Inclusion in this directory is not an endorsement.